Federal grants to Phase Genomics Inc
Phase Genomics Inc in Seattle, Washington received $10.9 million in federal grants from fiscal 2021 to 2025, across 9 awards. Its largest program was Allergy and Infectious Diseases Research, with $5.1 million. In fiscal 2025 it was awarded $299,163.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$10.9 million
- Awards9
- Awarded in FY 2025$299,163
- Largest award$2.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 4 | $2.7 million |
| FY 2022 | 3 | $2.7 million |
| FY 2023 | 4 | $3.2 million |
| FY 2024 | 2 | $2.1 million |
| FY 2025 | 1 | $299,163 |
Programs that fund Phase Genomics Inc
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 5 | $5.1 million |
| Cancer Detection and Diagnosis Research | 2 | $4.0 million |
| Child Health and Human Development Extramural Research | 1 | $1.7 million |
| Small Business Innovation Research (SBIR) Program / Small Business Technology Transfer (STTR) Program | 1 | $99,866 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 8 | $10.8 million |
| Department of Agriculture | 1 | $99,866 |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Chromosomal aberration detection in ffpe tissue using proximity ligation sequencing - abstract the detection of chromosomal aberrations is a frontline diagnostic for the spectrum of blood neoplasms. Chromosomal aberrations, such as translocations, inversions, deletions and insertions, have been hist | Cancer Detection and Diagnosis Research | September 25, 2023 | $2.0 million |
| Ai-based aml risk stratification using next generation cytogenomics - abstract chromosome aberrations are a hallmark of acute myeloid leukemia and offer mechanistic and prognostic insights into disease. As such, a combination of cytogenetic assays are routinely applied as a part of the aml diagnosti | Cancer Detection and Diagnosis Research | June 8, 2023 | $2.0 million |
| Therapeutic phage host-range prediction using proximity-guided metagenomics and artificial intelligence - abstract there is growing interest in the therapeutic application of phage for treatments of antibiotic-resistant infections and gut microbiome-related disorders. Phage therapies have the advant | Allergy and Infectious Diseases Research | May 26, 2022 | $2.0 million |
| A next-generation method for cytogenomics using hi-c proximity ligation sequencing | Child Health and Human Development Extramural Research | April 26, 2021 | $1.7 million |
| A method for the culture-free discovery and host affiliation of novel viruses from metagenomic samples - abstract in this application, we propose to develop a novel reagent kit and accompanying analytic software platform that employs hi-c technology for a user-friendly method to assemble viral genom | Allergy and Infectious Diseases Research | February 8, 2021 | $1.6 million |
| A proximity ligation method to track mobile element hosts | Allergy and Infectious Diseases Research | December 23, 2020 | $895,817 |
| Harnessing mrna vaccine technology for precision antimicrobial delivery - abstract the rise of antimicrobial resistance (AMR) presents an urgent global health crisis, projected to surpass cancer as the second leading cause of death by 2050. Existing antibiotics are becoming increasingly ineffective | Allergy and Infectious Diseases Research | April 22, 2025 | $299,163 |
| Biological validation of phage host-range identified by proximity guided metagenomics - abstract phages are viruses that infect bacteria and have the potential to be used as a clinical tool for treating infectious diseases and gut microbiome-related disorders. Understanding phage-host interactions c | Allergy and Infectious Diseases Research | May 25, 2023 | $299,132 |
| Strain-level diagnostics of fungal crop pathogens enabled by fully-phased isolate genomes | Small Business Innovation Research (SBIR) Program / Small Business Technology Transfer (STTR) Program | March 17, 2021 | $99,866 |
Questions people ask
How much federal grant money does Phase Genomics Inc get?
$10.9 million in 9 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Phase Genomics Inc the most?
The Department of Health and Human Services, with $10.8 million in 8 awards. The Department of Agriculture follow.
What is Phase Genomics Inc's largest federal grant?
$2.0 million under Cancer Detection and Diagnosis Research, with its first action in the period on September 25, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Phase Genomics Inc?
Its largest are Allergy and Infectious Diseases Research, Cancer Detection and Diagnosis Research and Child Health and Human Development Extramural Research.
Other grant recipients in Seattle
- University of Washington
- Central Puget Sound Regional Transit Authority
- Fred Hutchinson Cancer Center
- King County Metro Transit
- Port of Seattle
- Seattle Children's Hospital
- Allen Institute
- Seattle Housing Authority
Largest federal grant recipients in Washington · Federal grants in Washington